APPLICATION
NDA017573
TYPE
NDA
ORIGINAL APPROVAL
1976-05-12
LATEST ACTION
2000-08-30
ROUTE
INHALATION
DOSAGE FORM
AEROSOL, METERED
MARKETING STATUS
Discontinued
Products
VANCERILDiscontinued
BECLOMETHASONE DIPROPIONATE 0.042MG/INH · AEROSOL, METERED · INHALATION
Approval history
2000-08-30Manufacturing (CMC) · Supplement 45 · priorityAP
2000-07-26Manufacturing (CMC) · Supplement 44 · priorityAP
1999-03-11Manufacturing (CMC) · Supplement 41 · priorityAP
1995-11-27Manufacturing (CMC) · Supplement 39 · priorityAP
1995-08-03Manufacturing (CMC) · Supplement 38 · priorityAP
1989-08-23Labeling · Supplement 36 · priorityAP
1988-08-02Manufacturing (CMC) · Supplement 34 · priorityAP
1988-02-01Manufacturing (CMC) · Supplement 30 · priorityAP
1987-09-24Manufacturing (CMC) · Supplement 31 · priorityAP
1986-07-08Manufacturing (CMC) · Supplement 29 · priorityAP
1986-03-06Manufacturing (CMC) · Supplement 28 · priorityAP
1986-02-24Manufacturing (CMC) · Supplement 26 · priorityAP
1986-02-24Labeling · Supplement 27 · priorityAP
1985-02-21Manufacturing (CMC) · Supplement 23 · priorityAP
1985-01-02Manufacturing (CMC) · Supplement 24 · priorityAP
1984-12-17Manufacturing (CMC) · Supplement 21 · priorityAP
1982-02-04Manufacturing (CMC) · Supplement 19 · priorityAP
1982-02-02Manufacturing (CMC) · Supplement 18 · priorityAP
1981-12-03Manufacturing (CMC) · Supplement 17 · priorityAP
1981-06-30Labeling · Supplement 14 · priorityAP
1981-06-20Manufacturing (CMC) · Supplement 16 · priorityAP
1981-03-23Manufacturing (CMC) · Supplement 15 · priorityAP
1981-01-13Manufacturing (CMC) · Supplement 12 · priorityAP
1981-01-13Labeling · Supplement 13 · priorityAP
1980-11-24Labeling · Supplement 11 · priorityAP
1980-06-23Labeling · Supplement 9 · priorityAP
1979-06-26Manufacturing (CMC) · Supplement 6 · priorityAP
1979-06-15Manufacturing (CMC) · Supplement 7 · priorityAP
1979-06-14Labeling · Supplement 2 · priorityAP
1979-06-14Labeling · Supplement 5 · priorityAP
1979-04-13Manufacturing (CMC) · Supplement 3 · priorityAP
1979-04-06Manufacturing (CMC) · Supplement 4 · priorityAP
1979-03-27Labeling · Supplement 8 · priorityAP
1976-05-12Type 1 - New Molecular Entity · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.